TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: HS Quality of Life Measure (HiSQOL) Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Observations of Physical Aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observations of Prosocial Behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Observations of Relational Aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve for the first and last 96 hours of dosing (AUC96h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough plasma drug concentration at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular photopic distance corrected intermediate visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rational drug use status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency, severity, and persistence of AEs and AEs Grade 3 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of Acute Procedural Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the plasma drug concentration-time curve from 0 to last (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma drug concentration-time curve from 0 to infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum or peak concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consult Response Time (CRT)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pre-preparation Time (PPT)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severity of wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of endotracheal tubes correctly placed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-treatment related events
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor Necrosis Factor-Alpha (TNF-Alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Interleukin-1 Beta (IL-1β)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Animal Source Foods Consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lung Function Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Airway Inflammation (NIOX VERO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Usability level of the tracking application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of advanced cancer
Endpoint domain: Mortality/survival
Primary endpoint: Duration of laryngeal vestibule closure (dLVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to laryngeal vestibule closure (Time-to-LVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in Lymphocyte activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in cytokine production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in serum inflammatory cytokine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes from baseline in global cognitive composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in serum brain-derived neurotrophic factor (pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mucosal healing in IBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants who experience complications over time
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pain score over time as measured on a pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cosmetic appearance over time as measured by the Oxford Finger Nail Appearance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in upper extremity function over time as measured by the QuickDash score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: MRI changes in the paraventricular nucleus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PET changes in the paraventricular nucleus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Marginal Ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Melatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of sedation and analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary patency at one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Readmission rates among COPD patients
Endpoint domain: Mortality/survival
Primary endpoint: Good-quality blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed blastocyst formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Annualized joint bleeding rate (AjBR) for treated bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Annualized joint bleeding rate (AjBR) for all (treated and untreated) bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Target joint development, resolution and/or recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistent Pain Relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anxiety as measured by GAD-2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety as measured by the FASA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Program Feedback Scale (PFS) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathological complete response of primary lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality of Life 12 months after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EQ-5D-5L descriptive index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patients with no antibodies to Rh0 (D) antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Primary Safety Outcome 1
Endpoint domain: Adverse events/effects
Primary endpoint: Primary Safety Outcome 2
Endpoint domain: Adverse events/effects
Primary endpoint: Primary Efficacy Outcome
Endpoint domain: Physiological/clinical
Primary endpoint: Level of confidence in managing BPPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Two-Minute Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction rate of the Pittsburgh Sleep Quality Index (PSQI) score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Urinary incontinence related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of developing constipation
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of endocytoscopy for diagnosing UGI aGvHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAT Time to Initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Staying on Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MAT Days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of pathological acid reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of local and systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Time to pregnancy in days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Accuracy of stoma implementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Overnight Levels of Glutathione (GSH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Change in Pre- to Post-Sleep GSH Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quick Disabilities of Arm, Shoulder & Hand
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cumulative HIV diagnoses
Endpoint domain: Mortality/survival
Primary endpoint: Antenatal care registrations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: detection rate of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: detection rate of clinical significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Brain Activation Pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average drinks per drinking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of sex under influence of alcohol/drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change from baseline in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in RV (right ventricular) area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in RA (right atrial) area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of Falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of post-operative acute kidney injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prothrombin time sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Factor II sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Factor V sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Factor VII sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Factor X sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Treatment-limiting radiation therapy complication
Endpoint domain: Adverse events/effects
Primary endpoint: Intolerance of Uncertainty-12 Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety Sensitivity-3 Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PROMIS Anxiety Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Take homes received over time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline in IL-6 level at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline of presence/absence of active key co-infections at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change of HbA1c level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heart rate data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Temperature data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Negative Urinary Stress Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Subjective Outcome With Improvement in the Patient Global Impression of Improvement (PGI-I)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in visual analogue scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of device related adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Gixam's diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle fiber type composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants meeting treatment failure
Endpoint domain: Adverse events/effects
Primary endpoint: Intrapartum fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature of parturients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of intrapartum fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Postoperative Organ failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ratio of FEV1/forced vital capacity (FVC) for airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in total lung capacity (TLC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of subjects with adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Premature treatment discontinuation due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Blood levels of NT-pro BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nasopharyngeal carriage of vaccine-type Streptococcus pneumoniae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Solicited local and systemic adverse events following immunisation (AEFI)
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited or unsolicited severe adverse events (SAE) following vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of acute adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluating quality of life with questionnaire one week after the treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Non-invasive tear break-up time (NIBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall Risk Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Covid-19 Functional Status Scale (PCFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the NNC0480-0389 plasma concentration-time curve from time 0 to infinity after a single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration of NNC0480-0389 after a single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum magnesium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Movement Assessment Battery for Children Checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vineland Adaptive Behavior Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceived Motor Competence Scale Parent Report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Motor Competence Scale Child Report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Brief Observation of Social Communication Change
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Parenting Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PEC index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Wehmeyer score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mansoura score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking Index for Spinal Cord Injury - II (WISCI-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decline in KCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage of patients with IPF who develop cardiovascular comorbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distinction of neutrophil subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the Brief Child Abuse Potential Inventory (BCAP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on restricted/repetitive behavior in ASD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' Satisfaction Interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the bCPAP device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the blenders device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the bCPAP and blenders device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Self-management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic accuracy of blood test for angioedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Severity and function of patellofemoral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Triglyceride carbon content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Degree of saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trabecular bone microarchitecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Safety and tolerability of treatment combinations
Endpoint domain: Adverse events/effects
Primary endpoint: Preliminary efficacy of treatment combination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in patients performance status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Velocity of center of pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medio-lateral range of sway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior-posterior range of sway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained clinical cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of goserelin over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUC0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with new DWI-positive lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Hemoglobin A1C %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in splanchnic venous capacitance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: POTS postprandial symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pattern of Intestinal Parasitic Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Spine Rotation Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoliosis Research Society (SRS-22 test)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Brace Questionnaire (BrQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intracardiac hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Confirmed Worsening in MDS-UPDRS Parts II and III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: London Tower Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of critical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of 1-year recurrent ischemic stroke
Endpoint domain: Mortality/survival